How Big is the Generic Injectable Market | Growth Insights & Size 2025

Q: How big is the generic injectable market?

The generic injectable market was exhibited at USD 85 Billion in 2024 and is expected to reach USD 120 Billion by 2031

Q: What is the growth rate of the generic injectable market?

The generic injectable market is expected to grow at a CAGR of 5% during 2025–2031.

Q: What are the main drivers of market growth?

Growth is driven by rising chronic diseases, patent expiries, affordability of generics, and healthcare expansion.

Q: Who are the key players in the market?

Major players include Pfizer, Fresenius Kabi, Teva, Sandoz, and Dr. Reddy’s.

Q: How does 6W market outlook report help businesses in making decisions?

6W monitors the market across 60+ countries Globally, publishing an annual market outlook report that analyses trends, key drivers, Size, Volume, Revenue, opportunities, and market segments. This report offers comprehensive insights, helping businesses understand market dynamics and make informed decisions.

Q: Do you also provide customisation in the market study?

Yes, we provide customisation as per your requirements. To learn more, feel free to contact us on sales@6wresearch.com

Code: MTA6352

Publication Date: Jul 2025

What is the size of Generic Injectable Market?

According to 6Wresearch internal database and industry insights, Global Generic Injectables Market was valued at USD 85 Billion in 2024 and is expected to reach USD 120 Billion by 2031, growing at a compound annual growth rate of 5.00% during the forecast period (2025-2031).

View Main Report

Schedule Analyst Call

Due to several growth factors including the rising chronic disease prevalence, patent expiries of branded injectables, and increasing healthcare access in emerging economies, the generic injectable market is predicted for growth in the coming years.

Key Growth Drivers of the Generic Injectable Market

Rising burden of chronic conditions such as cancer, diabetes, and cardiovascular diseases
Patent cliff of blockbuster biologics and branded injectable drugs
Growing demand for cost-effective treatment options
Expansion of hospital and clinical infrastructure in developing regions
Faster FDA approvals and regulatory support for generic formulations

Generic Injectable Market Trends

Generic injectable market is moving forward with some strong trends such as rapid expansion in oncology, diabetes care, and infectious disease segments. Also, the demand for long-acting injectables and biosimilar injectables is on the rise. And prefilled syringes and auto-injectors are gaining traction for ease of administration. Contract manufacturing and outsourcing are playing a key role in scaling up production. Regionally, the North America and Asia-Pacific are emerging as major markets for both demand and production.

Emerging Developments in the Generic Injectable Market

Generic injectable market is experiencing growth over the years as the market is focusing on ready-to-use and dual-chamber syringes for improved drug stability and patient safety. Also, the investment is rising in complex injectables such as liposomal formulations and depot injections. The artificial intelligence and digital monitoring are being introduced to support injectable drug adherence and safety tracking. Further, sustainable packaging solutions and cold-chain innovations are enhancing storage and transport efficiency in the injectable supply chain.